ITGA4 (CD49d) acts as a part of the very late antigen-4 (VLA-4) and has been studied in the context of chronic lymphocytic leukemia (CLL), where it has been found to represent an adverse prognostic marker [27–29]. The gene discussed is ITGA4; the disease is B-cell chronic lymphocytic leukemia.